SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bob Swift who wrote (2864)5/19/1999 11:03:00 PM
From: BMcV  Read Replies (1) of 10280
 
I would hope that if SGP were to license Nori it would not be just to kill it for competitive purposes, since that wouldn't help us at all. But I agree that if DCL isn't great, or if Nori can be differentiated in some meaningful way (maybe just that it works?), SGP could bite. Maybe it's not the Claritin franchise they're interested in protecting, but the allergy franchise. They obviously have the sales expertise, reputation, contacts, etc., in that area.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News